best phd programs in cancer biology

Cancer Biology Graduate Program at Emory University

"The Cancer Biology Graduate program provides outstanding PhD training in three areas that correspond to the three scientific focus groups of the Winship Cancer Institute."

"The Winship Cancer Institute of Emory University (Winship) serves as a hub for many of the research activities within the Cancer Biology Graduate program."

"The Graduate program in Cancer Biology (CB) has a diverse membership from over 15 different departments across the Emory campus, both basic science and clinical."

"The major goal of the Cancer Biology Graduate program is to provide outstanding PhD training opportunities for future leaders in the different aspects of cancer research in preparation for a diversity of career paths in research, teaching and medicine from academia to industry."

• Slide 1: "The Cancer Biology Graduate program provides outstanding PhD training in three areas that correspond to the three scientific focus groups of the Winship Cancer Institute."
• Slide 2: "The Winship Cancer Institute of Emory University (Winship) serves as a hub for many of the research activities within the Cancer Biology Graduate program."
• Slide 3: "The Graduate program in Cancer Biology (CB) has a diverse membership from over 15 different departments across the Emory campus, both basic science and clinical."
• Slide 4: "The major goal of the Cancer Biology Graduate program is to provide outstanding PhD training opportunities for future leaders in the different aspects of cancer research in preparation for a diversity of career paths in research, teaching and medicine from academia to industry."

About the Program

Emory University's Cancer Biology Graduate Program (CB) is a small, interdisciplinary graduate program that provides outstanding training opportunities in every aspect of cancer research. Students in the CB program have access to state-of-the-art facilities and equipment, including state-of-the-art core facilities.

The CB program is designed to provide students with comprehensive training in the biological and molecular basis of cancer, including the study of human cancers using both model systems and clinical materials.

The fields of research covered by the CB program include molecular and cellular biology, genetics and epigenetics, cancer immunology, signal transduction, genetic engineering, nanotechnologies, and many other disciplines used to understand the development, progression, and treatment of cancer.

The program aims to provide advanced training for scientists who will work in academic, industrial, or government research. These students have a chance to train with some of the best minds in cancer research and treatment—preparing them for careers as bench scientists and leaders.

Research in this area concentrates on Cancer Cell Metabolism, Stress and Survival, Invasion and Metastasis, and Genetic and Epigenetic alterations. You will study the biological mechanisms by which cancer cells establish themselves and form a neoplastic tissue.

Cancer Prevention and Control

Research in this area includes Cancer Epidemiology, Biomarkers, and Chemoprevention; Health Behavior Research; Symptom Management and Control; and Health Outcomes and Quality of Care. The aims of this program are to reduce cancer risk, incidence, morbidity, and mortality, and to improve the quality of life of cancer patients and survivors.

Cancer Immunology

Research in this area takes place at the intersection of cancer biology and immunology. This work involves the study of how tumors evade the immune system, and how the immune system can be modulated to  recognize and eradicate tumor cells.

Discovery and Developmental Therapeutics

Research in this area focuses on exploiting the knowledge acquired from the study of cancer formation to develop novel therapeutics. Faculty members in this program interrogate various molecular targets to discover new agents and new therapeutic combinations, and test those drugs in animal models, with the ultimate goal of establishing clinical trials.

Cancer Biology graduates are highly sought after by employers in various industries, cancer research laboratories, biomedical research firms, and government agencies. They work as researchers, laboratory managers, and technical specialists in the industry and pursue independent research careers at universities or medical schools.

Life at Emory & Atlanta

Life at Emory University is one of the most exciting and intellectually stimulating experiences you could ask for.

A diverse, inclusive community welcomes students and faculty from all over the world. You'll find plenty of opportunities to get involved in campus life—and many resources available that will help you thrive as an Emory student.

The university has consistently ranked among the top 20 institutions nationally for NIH research support and was named one of the "New Ivies" by Newsweek—a tribute to both its academic excellence, as well as dedication to teaching.

Our faculty members are some of the most distinguished scholars in their fields and work closely with undergraduate students on research projects, independent study courses, or senior thesis projects.

Located just 6 miles northeast of downtown Atlanta, Emory's 704-acre campus is in a beautifully wooded area that offers students a peaceful environment to study but also provides easy access to Atlanta's bustling cultural scene.

Latest News Stories

Ph.D. in Molecular Cancer Biology

General info.

• Faculty working with students: 41
• Students: 34
• Part time study available: No
• Application terms: Fall
• Application deadline: November 30

Ann Marie Pendergast Director of Graduate Studies University Program in Molecular Cancer Biology Box 3813 Duke University Medical Center Durham, NC 27710

Phone: (919) 613-8600

Emails: [email protected] ,  [email protected]

Website:  https://pcb.duke.edu/education-training/molecular-cancer-biology-phd-program

Program Description

The molecular cancer biologists at Duke University seek to understand the complex regulatory mechanisms that govern mammalian cell growth and differentiation, discern how these mechanisms are perturbed in malignant cells, and how our knowledge of these regulatory mechanisms might lead to improved anti-cancer therapy. This research covers the boundaries of disciplines such as pharmacology, biochemistry, molecular biology, genetics, genomics and cell biology, and has increased our knowledge of the basic mechanisms underlying growth regulation. To understand how and why these mechanisms fail, and how their failure results in the initiation of cancer requires an understanding of the molecules involved in chemically and cellularly precise terms, so as to decipher their ultimate impact on the growth and development of the organism.

The Program in Molecular Cancer Biology includes faculty from thirteen (13) participating departments. Program scientists are actively engaged in dissecting the regulatory networks that control the processes of growth and development at the cellular and molecular levels, and the defects that lead to oncogenic transformation. The approaches used by the investigators range from classical genetics and genomics to cell and molecular biology and protein biochemistry. An ultimate goal is identifying novel candidates for therapeutic intervention of oncogenesis. Graduate training in this program is greatly enhanced by the interaction between investigators.

Molecular Cancer Biology Program Goals:

• To train students in creative and innovative approaches to dissecting the regulatory networks that control the molecular, cellular and organismic processes required for tumor progression and metastasis. 
• The approaches used include genomics, proteomics, genetics, bioinformatics, state-of-the art omics technologies, cell biology, molecular biology and protein biochemistry.
• A major goal is to identify novel candidates for therapeutic intervention in the treatment of cancer.
• Graduate training in this program is greatly enhanced by the collaborative interactions among investigators across the University and the School of Medicine.
• The curricula are designed to provide a strong foundation in cancer biology while maintaining flexibility to pursue elective courses tailored for the student’s future research interests.
• Molecular Cancer Biology: PhD Admissions and Enrollment Statistics
• Molecular Cancer Biology: PhD Completion Rate Statistics
• Molecular Cancer Biology: PhD Time to Degree Statistics
• Molecular Cancer Biology: PhD Career Outcomes Statistics

Application Information

Application Terms Available:  Fall

Application Deadline:  November 30

Graduate School Application Requirements See the Application Instructions page for important details about each Graduate School requirement.

• Transcripts: Unofficial transcripts required with application submission; official transcripts required upon admission
• Letters of Recommendation: 3 Required
• Statement of Purpose: Required
• Résumé: Required
• GRE Scores – GRE General: Optional This program does not require applicants to provide GRE (Graduate Record Examination) or other graduate entrance exam scores, but does allow you to upload scores if you feel they enhance your application. If you choose to submit test scores, you may enter them on the Test Scores page. If you choose to enter self-reported test scores, official test scores will become a required component of your application.
• English Language Exam: TOEFL, IELTS, or Duolingo English Test required* for applicants whose first language is not English *test waiver may apply for some applicants
• GPA: Undergraduate GPA calculated on 4.0 scale required

Department-Specific Application Requirements (submitted through online application)

Writing Sample None required

Additional Components Optional Video Essay: How would a Duke PhD training experience help you achieve your academic and professional goals? Max video length 2 minutes; record externally and provide URL in application.

We strongly encourage you to review additional department-specific application guidance from the program to which you are applying: Departmental Application Guidance

List of Graduate School Programs and Degrees

• Skip to Content
• Catalog Home
• Cancer Biology, Ph.D.

The graduate program in cancer biology offers a course of study and research leading to the Ph.D. degree. Although a master’s degree is offered under special circumstances, students are not admitted for a master’s degree.

The Cancer Biology Graduate Program was established at the McArdle Laboratory for Cancer Research in 1940 as the first graduate program in the United States to offer a degree in basic cancer research. The program now includes more than 50 faculty trainers from multiple departments including Oncology, Medicine, Human Oncology, Cell and Regenerative Biology, Medical Microbiology and Immunology, and others. This interdepartmental structure offers students remarkably diverse training opportunities that span the entire breadth of cancer biology research from haploid or diploid genetics, viral and chemical carcinogenesis, eukaryotic cell and molecular biology, virology, molecular toxicology, and whole-animal carcinogenesis. Through the graduate curriculum, students are introduced to the body of knowledge that has been derived directly from experiments on the induction, properties, and therapy of cancer, and receive the necessary background to conduct independent research.

Curriculum requirements are designed to be flexible, providing a maximal opportunity for specialization within this multidisciplinary field. Students learn through core and elective courses; by participation in seminars, conferences, and journal clubs related to their specific areas of expertise; and most important, from their research advisors. Students who join the program select research advisors after conducting a minimum of three month-long rotations in different laboratories during the first semester. After choosing an advisor, students will also create an advisory committee of five faculty members who will provide guidance throughout the process of earning the Ph.D. degree. The average time to complete the Ph.D. is 5.5 years. The program prepares students for careers in teaching and research in academia, government, and industry.

Please consult the table below for key information about this degree program’s admissions requirements. The program may have more detailed admissions requirements, which can be found below the table or on the program’s website.

Graduate admissions is a two-step process between academic programs and the Graduate School. Applicants must meet the minimum requirements of the Graduate School as well as the program(s). Once you have researched the graduate program(s) you are interested in, apply online .

Students seeking admission to the program must complete a bachelor's degree in biology, biochemistry, chemistry, molecular biology, or a related area from an accredited college or university and should have a grade point average of at least 3.0 (on a 4.0 scale). The background of the student should include basic courses in these areas as well as several advanced courses in chemistry, microbiology, biochemistry, genetics, physiology, and molecular biology. Prior laboratory research experience is highly desirable.

Applicants must submit a completed application online, personal statement (reasons for graduate study), unofficial college transcripts, updated CV/resume (highlighting laboratory experience), and three letters of recommendation.

Graduate School Resources

Resources to help you afford graduate study might include assistantships, fellowships, traineeships, and financial aid.  Further funding information is available from the Graduate School. Be sure to check with your program for individual policies and restrictions related to funding.

Program Resources

The program is committed to ensure continuing financial support for all cancer biology Ph.D. students in good standing. Financial support includes a competitive stipend and tuition remission. All graduate students are also eligible for comprehensive health insurance. Ph.D. students are supported from a variety of different sources including research assistantships from faculty research grants, fellowships, and NIH training grants. There is no teaching requirement for cancer biology students; however, many opportunities exist on campus for those who wish to gain teaching experience.

Students are admitted into the Cancer Biology Program as a Research Assistant (RA) unless they have received a fellowship or training grant. Find more information here .

Minimum Graduate School Requirements

Major requirements.

Review the Graduate School minimum academic progress and degree requirements , in addition to the program requirements listed below.

MODE OF INSTRUCTION

Mode of instruction definitions.

Accelerated: Accelerated programs are offered at a fast pace that condenses the time to completion. Students typically take enough credits aimed at completing the program in a year or two.

Evening/Weekend: ​Courses meet on the UW–Madison campus only in evenings and/or on weekends to accommodate typical business schedules.  Students have the advantages of face-to-face courses with the flexibility to keep work and other life commitments.

Face-to-Face: Courses typically meet during weekdays on the UW-Madison Campus.

Hybrid: These programs combine face-to-face and online learning formats.  Contact the program for more specific information.

Online: These programs are offered 100% online.  Some programs may require an on-campus orientation or residency experience, but the courses will be facilitated in an online format.

  CURRICULAR REQUIREMENTS

Required courses .

The curriculum for Cancer Biology is designed to introduce you to research related to the induction, properties, and therapy of cancer and to ensure that you have the necessary background in one or more areas of related, fun­damental science to enable you to do original research.  Courses are drawn from the Department of Oncology as well as vari­ous related departments, including Bacteriology, Biochemistry, Biomolecular Chemistry, Chemistry, Genetics, Human Oncology, Medical Microbiology and Immunology, Pathology and Laboratory Medicine, and Pharmacology. 

The Graduate School at UW-Madison requires PhD students to complete a minimum of 51 credits in order to obtain a PhD Degree. These credits are fulfilled via core curriculum courses, 990 research, and electives. Courses numbered below 300, audit, and pass/fail do not satisfy the minimum requirement. It is suggested that you take approximately 2 courses per semester with the remaining credits being 990 research. All courses must be completed by the end of your second year, before completing the Preliminary Exam.

Beginning in your second year, you will be required to give an annual, formal presentation in the Cancer Biology Student/Postdoc Seminar Series. You will register for ONCOLOGY 901 Seminar  during the semester in which you present. Your seminars will be recorded and you will receive feedback from the seminar course instructor to help improve your public speaking and presentation skills.   Attendance at this seminar series is required . 

In addition, you are expected to attend the Cancer Biology Seminar throughout your graduate career (no registration required). The Cancer Biology Seminar, which features local and outside faculty speakers, is held on Wednesdays at 10:30 a.m. in 1345 HSLC. The schedule is posted on the McArdle website .

Students will enroll in up to 12 credits per semester as pre-dissertators (only 2 credits during the summer term).

Students may select electives from the list below in consultation with their advisor.

Elective Coursework

Graduate school policies.

The  Graduate School’s Academic Policies and Procedures  provide essential information regarding general university policies. Program authority to set degree policies beyond the minimum required by the Graduate School lies with the degree program faculty. Policies set by the academic degree program can be found below.

Major-Specific Policies

Prior coursework, graduate work from other institutions.

With program approval, students are allowed to count no more than 9 credits of graduate coursework from other institutions. Coursework earned five or more years prior to admission to a master’s degree or doctoral degree is not allowed to satisfy requirements.

UW–Madison Undergraduate

With program approval, students are allowed to count no more than 7 credits numbered 300 or above from a UW–Madison undergraduate degree.

UW–Madison University Special

With program approval, students are allowed to count no more than 15 credits of coursework numbered 300 or above taken as a UW–Madison Special student. Coursework earned ten or more years prior to admission to a doctoral degree is not allowed to satisfy requirements.

A semester GPA below 3.0 or an incomplete grade (I) will result in the student being placed on academic probation. If a semester GPA of 3.0 is not attained or the Incomplete grade is not cleared during the subsequent semester of full- time enrollment, the student may be dismissed from the program or allowed to continue for 1 additional semester based on advisor appeal to the Graduate School.

ADVISOR / COMMITTEE

All students are required to have an advisor. Students must create a certification committee (advisor plus four additional faculty members) by the end of their first year. After passing their preliminary examination, students are required to conduct a progress report meeting with their certification committee each year. Failure to do so may result in a hold being placed on the student’s registration.

CREDITS PER TERM ALLOWED

Time constraints.

All doctoral students must pass their preliminary examination by the end of their second year (August 31). Under special circumstances, a one-semester extension may be granted when justified in writing by the student and advisor.

A candidate for a doctoral degree who fails to take the final oral examination and deposit the dissertation within five years after passing the preliminary examination may be required to take another preliminary examination and to be admitted to candidacy a second time.

Doctoral degree students who have been absent for ten or more consecutive years lose all credits that they have earned before their absence. Individual programs may count the coursework students completed prior to their absence for meeting program requirements; that coursework may not count toward Graduate School credit requirements.

grievances and appeals

These resources may be helpful in addressing your concerns:

• Bias or Hate Reporting  
• Graduate Assistantship Policies and Procedures
• Office of the Provost for Faculty and Staff Affairs
• Dean of Students Office (for all students to seek grievance assistance and support)
• Employee Assistance (for personal counseling and workplace consultation around communication and conflict involving graduate assistants and other employees, post-doctoral students, faculty and staff)
• Employee Disability Resource Office (for qualified employees or applicants with disabilities to have equal employment opportunities)
• Graduate School (for informal advice at any level of review and for official appeals of program/departmental or school/college grievance decisions)
• Office of Compliance (for class harassment and discrimination, including sexual harassment and sexual violence)
• Office of Student Conduct and Community Standards (for conflicts involving students)
• Ombuds Office for Faculty and Staff (for employed graduate students and post-docs, as well as faculty and staff)
• Title IX (for concerns about discrimination)

Grievance Policy for Graduate Programs in the School of Medicine and Public Health

Any student in a School of Medicine and Public Health graduate program who feels that they have been treated unfairly in regards to educational decisions and/or outcomes or issues specific to the graduate program, including academic standing, progress to degree, professional activities, appropriate advising, and a program’s community standards by a faculty member, staff member, postdoc, or student has the right to complain about the treatment and to receive a prompt hearing of the grievance following these grievance procedures. Any student who discusses, inquiries about, or participates in the grievance procedure may do so openly and shall not be subject to intimidation, discipline, or retaliation because of such activity. Each program’s grievance advisor is listed on the “Research” tab of the SMPH intranet .

This policy does not apply to employment-related issues for Graduate Assistants in TA, PA and/or RA appointments.  Graduate Assistants will utilize the Graduate Assistantship Policies and Procedures (GAPP) grievance process to resolve employment-related issues.

This policy does not apply to instances when a graduate student wishes to report research misconduct.  For such reports refer to the UW-Madison Policy for Reporting Research Misconduct for Graduate Students and Postdoctoral Research Associates .

Requirements for Programs

The School of Medicine and Public Health Office of Basic Research, Biotechnology and Graduate Studies requires that each graduate program designate a grievance advisor, who should be a tenured faculty member, and will request the name of the grievance advisor annually.  The program director will serve as the alternate grievance advisor in the event that the grievance advisor is named in the grievance.  The program must notify students of the grievance advisor, including posting the grievance advisor’s name on the program’s Guide page and handbook.

The grievance advisor or program director may be approached for possible grievances of all types.  They will spearhead the grievance response process described below for issues specific to the graduate program, including but not limited to academic standing, progress to degree, professional activities, appropriate advising, and a program’s community standards.  They will ensure students are advised on reporting procedures for other types of possible grievances and are supported throughout the reporting process.  Resources on identifying and reporting other issues have been compiled by the Graduate School.

• The student is advised to initiate a written record containing dates, times, persons, and description of activities, and to update this record while completing the procedures described below.
• If the student is comfortable doing so, efforts should be made to resolve complaints informally between individuals before pursuing a formal grievance.
• Should a satisfactory resolution not be achieved, the student should contact the program’s grievance advisor or program director to discuss the complaint. The student may approach the grievance advisor or program director alone or with a UW-Madison faculty or staff member. The grievance advisor or program director should keep a record of contacts with regards to possible grievances.  The first attempt is to help the student informally address the complaint prior to pursuing a formal grievance. The student is also encouraged to talk with their faculty advisor regarding concerns or difficulties.
• If the issue is not resolved to the student’s satisfaction, the student may submit a formal grievance to the grievance advisor or program director in writing, within 60 calendar days from the date the grievant first became aware of, or should have become aware of with the exercise of reasonable diligence, the cause of the grievance.  To the fullest extent possible, a grievance shall contain a clear and concise statement of the grievance and indicate the issue(s) involved, the relief sought, the date(s) the incident or violation took place, and any specific policy involved.
• The grievance advisor or program director will convene a faculty committee composed of at least three members to manage the grievance.  Any faculty member involved in the grievance or who feels that they cannot be impartial may not participate in the committee.  Committee composition should reflect diverse viewpoints within the program.
• The faculty committee, through the grievance advisor or program director, will obtain a written response from the person or persons toward whom the grievance is directed. The grievance advisor or program director will inform this person that their response will be shared with the student filing the grievance.
• The grievance advisor or program director will share the response with the student filing the grievance.
• The faculty committee will make a decision regarding the grievance. The committee’s review shall be fair, impartial, and timely.  The grievance advisor or program director will report on the action taken by the committee in writing to both the student and the person toward whom the grievance was directed.
• The grievant will be notified in writing, within 5 business days of the written appeal, acknowledging receipt of the formal appeal and establishing a timeline for the review to be completed.
• The senior associate dean or their designee may request additional materials and/or arrange meetings with the grievant and/or others.  If meetings occur, the senior associate dean or their designee will meet with both the grievant and the person or persons toward whom the grievance is directed.
• The senior associate dean or their designee will assemble an ad hoc committee of faculty from outside of the student’s graduate program and ask them to prepare a written recommendation on whether to uphold or reverse the decision of the program on the student’s initial grievance.  The committee may request additional materials and/or arrange meetings with the grievant and/or others.  If meetings occur, the committee will meet with both the grievant and the person or persons toward whom the grievance is directed.
• The senior associate dean or their designee will make a final decision within 20 business days of receipt of the committee’s recommendation.
• The SMPH Office of Basic Research, Biotechnology, and Graduate Studies must store documentation of the grievance for seven years. Grievances that set a precedent may be stored indefinitely.
• The student may file an appeal of the School of Medicine and Public Health decision with the Graduate School.  See the Grievances and Appeals section of the Graduate School’s Academic Policies and Procedures .

Time Limits

Steps in the grievance procedures must be initiated and completed within the designated time periods except when modified by mutual consent. If the student fails to initiate the next step in the grievance procedure within the designated time period, the grievance will be considered resolved by the decision at the last completed step.

Take advantage of the Graduate School's  professional development resources to build skills, thrive academically, and launch your career. 

• Articulates research problems, potentials, and limits with respect to theory, knowledge, or practice within the field of study.
• Formulates ideas, concepts, designs, and/or techniques beyond the current boundaries of knowledge within the field of study.
• Creates research, scholarship, or performance that makes a substantive contribution.
• Demonstrates breadth within their learning experiences.
• Advances contributions of the field of study to society.
• Communicates complex ideas in a clear and understandable manner.
• Fosters ethical and professional conduct.

For the most current list of faculty and descriptions of their research interests, visit the  program website .

• Requirements
• Professional Development
• Learning Outcomes

Contact Information

Cancer Biology Program, McArdle Laboratory for Cancer Research School of Medicine and Public Health [email protected] cancerbiology.wisc.edu

Hilary Gehin, Graduate Program Manager [email protected] 608-262-4682 6435 Wisconsin Institutes for Medical Research

Eric Johannsen, Director of Graduate Studies [email protected]

Grievance Advisor, Lisa Arendt, Associate Professor [email protected]

Grievance Advisor, Shigeki Miyamoto, Professor [email protected]

Graduate Program Handbook View Here

Graduate School grad.wisc.edu

• /​pdf/​
• Explore Graduate Opportunities
• Explore UW-​Madison's Undergraduate Opportunities
• Accounting and Information Systems
• African American Studies
• African Cultural Studies
• Agricultural and Applied Economics
• Agricultural and Life Sciences -​ College-​Wide
• Animal and Dairy Sciences
• Anthropology
• Art History
• Asian Languages and Cultures
• Atmospheric and Oceanic Sciences
• Bacteriology
• Biochemistry
• Biological Systems Engineering
• Biomedical Engineering
• Biostatistics and Medical Informatics
• Business -​ School-​Wide
• Cell and Regenerative Biology
• Chemical and Biological Engineering
• Chicana/​o and Latina/​o Studies
• Civil and Environmental Engineering
• Civil Society &​ Community Studies
• Classical and Ancient Near Eastern Studies
• Communication Arts
• Communication Sciences and Disorders
• Community and Environmental Sociology
• Computer Sciences
• Counseling Psychology
• Curriculum and Instruction
• Educational Leadership and Policy Analysis
• Educational Policy Studies
• Educational Psychology
• Electrical and Computer Engineering
• Engineering -​ College-​Wide
• Food Science
• Forest and Wildlife Ecology
• French and Italian
• Gaylord Nelson Institute for Environmental Studies
• Gender and Women's Studies
• German, Nordic, and Slavic
• Graduate -​ School-​Wide
• Horticulture
• Human Ecology -​ School-​Wide
• Industrial and Systems Engineering
• Information School
• Institute for Clinical and Translational Research
• Institute for Regional and International Studies
• Integrative Biology
• Journalism and Mass Communication
• Kinesiology
• La Follette School of Public Affairs
• Language Institute
• Language Sciences
• Law -​ School-​Wide
• Life Sciences Communication
• Management and Human Resources
• Materials Science and Engineering
• Mathematics
• Mead Witter School of Music
• Mechanical Engineering
• Medical Physics
• Medicine and Public Health -​ School-​Wide
• Nuclear Engineering and Engineering Physics
• Nursing -​ School-​Wide
• Nutritional Sciences
• Cancer Biology, M.S.
• Operations and Information Management
• Pharmacy -​ School-​Wide
• Planning and Landscape Architecture
• Plant Pathology
• Political Science
• Population Health Sciences
• Real Estate and Urban Land Economics
• Rehabilitation Psychology and Special Education
• Religious Studies
• Risk and Insurance
• Sandra Rosenbaum School of Social Work
• Soil Science
• Spanish and Portuguese
• Veterinary Medicine -​ School-​Wide
• Nondegree/​Visiting Student Guide
• Pharmacy Guide
• School of Medicine and Public Health Guide
• Undergraduate Guide
• Veterinary Guide

• Quick Links

Tools & Resources

• Events Calendar
• Strauss Health Sciences Library
• Department A-Z Directory
• Campus Directory
• Faculty & Staff Resources
• Supporter & Alumni Resources
• Student Resources
• Mental Health Resources
• University Policies

CU Campuses

Cu anschutz medical campus.

• CU Colorado Springs
• School of Dental Medicine
• Graduate School
• School of Medicine
• College of Nursing
• Skaggs School of Pharmacy and Pharmaceutical Sciences
• Colorado School of Public Health

Cancer Biology

Graduate program, cancer biology program.

The interdepartmental program leading to the PhD in Cancer Biology combines training in the basic biomedical sciences with opportunities to apply clinical and translational research to studies on human cancer.

Would you like to make a difference by supporting graduate student training?

Please consider donating to the Cancer Biology Graduate Program.

I chose to join the Cancer Biology PhD program at CU Anschutz for a variety of reasons. (1) Its collaborative atmosphere and commitment to high quality mentorship for students whether they intend on pursuing academic or non-academic future roles, (2) the program's genuine concern for student well-being and commitment to inclusivity to create an empowering and diverse learning environment, and (3) the wealth of opportunities to learn about every step of bringing discoveries from bench-to-bedside. In addition to gaining technical scientific knowledge from world-class scientists, I've personally had the pleasure of learning about patient experiences and clinical trial design from Medical Oncologists at UC Health and the process of cancer therapeutic commercialization from Business Development and Licensing professionals at CU Innovations. Such experiences have made me a more well-rounded and patient-centered Cancer Biologist. 

- Phoebe Cao, Cancer Biology PhD Candidate

I joined the Cancer Biology Program because I wanted to explore the fundamental molecular mechanisms by which cancer cells form tumors. CU Anschutz gives me the opportunity to work with brilliant scientists from different fields of cancer biology.

- Abraham Martinez, Cancer Biology PhD Candidate

I joined the Cancer Biology Graduate Program at CU Anschutz to accomplish my goals of improving the standard of care and quality of life for patients through cutting edge research. CU Anschutz has stellar resources, such as the Cancer Center and the hospital which further enhance my translational studies.

- Daniela Ortiz Chavez, Cancer Biology PhD Trainee

I chose to join the Cancer Biology Graduate Program because of the unique position for collaboration, which is essential in cancer research. The senior students and mentors guide new students and provide an excellent research environment. As an international student, the program embraces diversity and makes me feel welcome.

- Li-Wei Kuo, Cancer Biology PhD Candidate

News & Events

We Belong: Celebrating Diverse Role Models in Science

• Google Calendar

Rotation Talks

End of year celebration, rotation 3 ends.

• Donate to CANB
• Send me more information
• Summer Research Programs
• PIKE-PREP (Postbac Program)

WHAT ARE YOU LOOKING FOR?

Key searches, cancer biology and genomics, about the cancer biology and genomics phd program.

The PhD program in Cancer Biology and Genomics (CBG) focuses on training investigators in strategies to understand the mechanisms of cancer development and progression which includes cell biological and genomic approaches. The ultimate objective is to translate basic findings into diagnostics, treatments and ultimate cures.

The program applies a multidisciplinary approach toward these goals, with the full realization that cancers in different organs represent different diseases. However all cancers relate to uncontrolled cell proliferation with many cancers having a strong genetic predisposition. Consequently, major features of this program include the breadth of medically related interests and training and faculty characterized by wide and varied skills in many cancer-related research areas. To facilitate the application of multidisciplinary approaches to make cancer a disease of the past, close and regular contact between participating faculty of different disciplines and students is a major theme of this PhD program.

Explore more about Cancer Biology and Genomics in this infographic .

Complete the form below for information on our graduate programs. Your journey towards a rewarding academic experience starts here!

Wayne State University

School of medicine, cancer biology program cancer biology program, ph.d. program.

Our major basic scientific challenge in cancer biology research is to determine the underlying biological basis for malignancy and the clinical challenge is to apply this basic research to improve treatment of human cancers. To meet these challenges our Graduate Program in Cancer Biology has a scope and approach which transcends traditional department/discipline structures, while still providing knowledge and training in many disciplines including biochemistry, pathology, molecular biology, therapeutics, immunology, pharmacology and chemistry.  Ours therefore is an integrated inter-disciplinary graduate program.  Our program's goal is to develop within each student the approach to scientific thought and pursuit needed for original research as an independent cancer biology investigator.

The Ph.D. program consists of formal course work which provides a comprehensive education in the principles and research of cancer biology, as well as solid training in the core disciplines which serve modern-day cancer research.  Hence, graduates gain a broad understanding of the fundamental principles underlying this diverse field with in-depth knowledge in their dissertation discipline. Active participation in research seminars and original research are two basic elements of this program. The major element is training in the research techniques which comprise a sophisticated underpinning for future advances in cancer biology. Students must complete a publishable research project under a faculty mentor and successfully defend the dissertation research.

The program of each cancer biology student is tailored to their specific interests and research requirements. Previous educational experience is recognized so as to permit the student to progress as rapidly as possible. 

Since the program requires a broad understanding of cancer biology, a core curriculum is required.

Total credits above equal 34 credits

Also, a number of advanced cancer biology courses are provided from which the student will be required to choose 11 credit hours for a total of 45 coursework credits. A number of other courses are available to allow students to specialize with regard to a specific research discipline. 

It is expected that most course work will be completed in the first and second years. A written comprehensive qualifying exam is required by the end of the first year, followed by an oral exam of the proposed dissertation research. The third and subsequent years will be primarily devoted to dissertation research.  Forty-five credits of general research, including 30 credits of dissertation research, will complete the Graduate School requirements.

The Graduate Program in Cancer Biology provides research opportunities in many areas of Cancer Biology including Experimental Therapeutics, Metastasis, Breast Cancer, Carcinogenesis, Molecular Biology of Cancer, Cancer Immunology, as well as selected topics within the traditional departments of Pharmacology, Biochemistry, Immunology and Medicine. Students complete up to three laboratory rotations in the first year (one in each semester) after which he/she will choose a research project and a mentor.  At the end of the first year, the student must submit a Plan of Work. Following its acceptance, a permanent advisory committee is established. The progress of the student toward the goals of this program will be reviewed at frequent intervals and are required annually and the student advised accordingly.

Independent pursuit of research leading to results of publishable caliber is the prime evidence demonstrating the completion of the requirements remaining after a student has completed the prescribed coursework and been admitted to Ph.D. candidacy.  We offer a variety of research experiences in the broad field of Cancer Biology.  Although some students will be committed to a specific research area before they enter the program, others will want an opportunity to investigate projects in some detail before making a commitment. Research rotations provide an in-depth exposure to research prior to selecting a dissertation project. Seminars given by the faculty allow the students to become familiar with ongoing research in the program.

Since research is open-ended, the amount of time required for completion of a defensible dissertation cannot be predicted. Although the program is designed to require four to five years to complete, some variation in the length of the program for different students is to be expected.  Four years is a minimum expectation for this program. Realistic goals should be set and the student and dissertation mentor will discuss progress relative to these goals at frequent intervals. The final examination is the defense of the dissertation conducted by the student's Dissertation Committee. The program has no other formal requirements for successful completion of the Ph.D.

Application for the Graduate Program in Cancer Biology at the Barbara Ann Karmanos Cancer Institute of Wayne State University

To apply to the Graduate Program in Cancer Biology, send a personal statement, a curriculum vitae, a description of research experience, an official undergraduate transcript(s), a copy of GRE scores and three letters of reference to the following address. International applications are required to also send TOEFL scores. Dr. Anil Wali c/o Lanette Rowland Graduate Programs in Cancer Biology 329 Lande Building Wayne State University, School of Medicine 550 E Canfield Detroit MI 48201 Phone (313)577-1065 Fax (313)577- 4112 [email protected]

Download and complete the following pdf form: Download pdf Application Form Here

Also, complete the on-line application here

University of Colorado Denver | Anschutz Denver | Anschutz Medical Campus

2024-2025 academic catalog, cancer biology (phd).

The Cancer Biology Training Program at the University of Colorado Denver | Anschutz Medical Campus is an interdepartmental program leading to the PhD in Cancer Biology. The Cancer Biology Program combines training in the basic biomedical sciences with opportunities to apply clinical and translational research to studies on human cancer.

Our highly accomplished training faculty includes over 50 basic and clinical scientists from 13 departments and divisions. Our curriculum is rigorous, yet flexible, and provides opportunities for advanced study in cellular and molecular oncology, as well as the translational medical sciences. Our research community includes a NIH/NCI designated Comprehensive Cancer Center, which brings together scientists with diverse research approaches to focus on the problem of cancer. The training program in cancer biology is supported by a NIH/NCI T32 training grant that provides funding for pre and post-doctoral trainees.

Admissions Requirements

To apply for admission applicants must submit the following:

• Online Graduate School application.
• A $50.00 domestic and $75.00 international non-refundable application fee [credit card (on-line only), check, or money order]. No application will be processed unless this fee is paid.
• Electronic Transcripts should be sent to:  [email protected]
• If sending a physical transcript, please mail to:

University of Colorado Denver Graduate School Mail Stop C296 Fitzsimons Building, W5107 13001 E. 17th Place Aurora, CO 80045

• The most informative letters will come from Professors who have mentored you in your research experiences. Professors who have taught science classes you have been enrolled in, or whom you have worked with in an advisory capacity, are also good choices. We do not recommend that you ask postdocs, technicians or fellow students for letters. Likewise, members of the community are generally not good choices, as typically their understanding of biomedical PhD training, and hence their ability to evaluate your potential, is limited.

International students must meet ALL of the requirements above and those required by International Admissions. 

Degree Requirements

A minimum of 3 elective credits are required (as specified in the CANB handbook) in addition to the specified courses below.

Second Year

Fourth year & beyond, learning objectives.

The Ph.D. program in Cancer Biology trains graduate students to become proficient and successful investigators who are able to:

• Demonstrate a basic knowledge of central concepts in the biomedical sciences.
• Understand the current concepts in Cancer Biology.
• Read and critically evaluate the scientific literature.
• Formulate hypotheses based on current concepts in the field and design, conduct, and interpret their own research projects.
• Orally communicate ideas and research results effectively.
• Effectively communicate ideas and research results in written form.
• Integrate and apply the communication and research skills through oral presentations at scientific seminars, conferences, and other venues, submission of competitive applications for research funding, authorship of abstracts, peer-reviewed publications, and a thesis dissertation.

Training Goals Training in the Cancer Biology PhD Program is based on six comprehensive training fundamentals that strive to integrate knowledge bases with interrelated skills.

Laboratory based training Through conduct of laboratory-based research trainees utilize their didactic knowledge base; learn experimental design and hypothesis testing, implementation and problem solving, data interpretation and hypothesis revision, and oral and written communication skills.

Didactic knowledge base Our coursework provides students with a firm foundation in cancer biology and innovative technologies to enable them to conduct the most relevant and cutting-edge research.

Hypothesis driven research Our training includes a strong emphasis on skill development for hypothesis generation and testing. These skills are emphasized in course work, journal clubs, written and oral communication, clinical exposure and laboratory research.

Clinical relevance We believe that understanding the patient experience and the clinical relevance of their laboratory research will help students to better focus their research plan and develop more nuanced hypotheses. Many clinical related opportunities are available including clinic shadowing and special topics courses that include options to learn about clinical trial design, drug resistance, drug targeting of cancer subtypes, etc.

Communication skills Research advances are only achieved if scientific discovery is effectively communicated to the rest of the scientific community and the public. Written and oral presentation skills are developed by presentations in seminars and journal clubs, written research proposals and fellowship applications.

Career and professional development Opportunities for professional development are available throughout a student’s matriculation. These include strengths and goals evaluation, mentoring by the primary mentor and research advisory committee, exposure to various scientific career paths, and professional networking at scientific meetings.

Publication Requirement: Publications are the culmination of the research done in the lab. It is the obligation of all scientists to share their findings with their peers and the public. Students are required to have at least one primary, first-author paper submitted and in review at a peer-reviewed journal at the time of their thesis defense. The student’s manuscript should be the focus of their thesis work. Under exceptional circumstances, co-first author publications may fulfill this requirement with approval of the steering and thesis committees. The decision to let the student defend is at the discretion of the thesis committee and student’s mentor.

Rebecca Schweppe, PhD Professor Program Director [email protected]

Benjamin Bitler, PhD Associate Professor Interim Associate Program Director [email protected]

Evelin Zumba Program Administrator [email protected] [email protected] 

Print Options

Send Page to Printer

Print this page.

Download Page (PDF)

The PDF will include all information unique to this page.

CU Denver Undergraduate Catalog

A PDF of the entire Undergraduate catalog.

CU Denver Graduate Catalog

A PDF of the entire Graduate catalog.

CU Anschutz Catalog

A PDF of the entire Anschutz catalog.

Cancer center launches new PhD program in translational cancer biology

IU School of Medicine Oct 26, 2022

IU School of Medicine Indianapolis Campus

INDIANAPOLIS— The Indiana University Melvin and Bren Simon Comprehensive Cancer Center is now offering a new PhD program dedicated to clinically relevant research in cancer biology. In the PhD in Translational Cancer Biology program , students will complete research alongside faculty mentors who are leading researchers at the cancer center.

“The cancer center’s National Cancer Institute designation—particularly as a comprehensive center—means we excel not only at research, but also in helping build the next generation of cancer researchers,” said Harikrishna Nakshatri, PhD , associate director of education at IU Simon Comprehensive Cancer Center and director of the translational cancer research doctoral program. “We need to make sure there is a strong workforce available, and this PhD program will help us create the workforce needed for future research and drug discovery.”

The IU Simon Comprehensive Cancer Center is one of only 53 cancer centers in the nation to hold the prestigious comprehensive cancer center designation by the NCI. The center earned that designation, in part, because of its outstanding educational offerings.

This is the first PhD program in Indiana to focus on the clinical translation of cancer biology. Students enrolled in this program will have the opportunity to participate in clinical training such as shadowing oncologists and physician-scientists and observing tumor board reviews —opportunities uniquely available due to the program’s proximity to clinical care with IU School of Medicine.

Students will complete coursework and research that will translate to clinical applications for patients, including topics such as:

• Cancer prevention and control
• Cancer genomics
• Biomarkers of cancer progression
• Developing novel therapies for specific cancers
• The impact of cancer on quality of life
• Improving the quality of life for survivors

“We know that research cures cancer, and this program will cultivate the brilliant minds we need in our labs to develop tomorrow’s cures,” said Kelvin Lee, MD , director of the cancer center. “This program will uniquely prepare investigators to understand how lab research translates to patient treatments and outcomes.”

The first cohort of students will begin the program in fall 2023. Students pursuing this degree will apply through the IU School of Medicine Indiana Biomedical Gateway (IBMG) Program, which provides a shared first-year experience for all IU School of Medicine biomedical science PhD program students. Following that first year of coursework, students can choose the translational cancer biology PhD program. Students who have completed at least a bachelor’s degree and are interested in pursuing cancer biology research can apply.

The 90-credit-hour program will take approximately five years to complete. Learn more about the program .

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

SEARCH THE NEWSROOM

Subscribe to the news.

We've added you to our mailing list!

Sorry, there was a problem

Media Contacts

Related news.

School of Medicine Cell, Developmental and Cancer Biology

• Enter keyword Search

Cancer Biology Graduate Program

Message from the program director.

The Cancer Biology Program constitutes the foundation of basic science research of the OHSU Knight Cancer Institute. The overall goal of the Cancer Biology Program is to investigate the underlying cellular, genetic and molecular mechanisms in the development of cancer and in the regulation of both normal and abnormal cell growth. The scientific thrust of the program is in four related areas of investigation: Signal Transduction, Carcinogenesis/Genetic Instability, Apoptosis and the Tumor Microenvironment.

About the program

The Graduate Program in Cancer Biology is designed to train students for a career in basic and applied cancer research. Modern cancer research is based on a broad range of technical skills including: Molecular Biology, Cell Biology, Genetics, Biochemistry, and Bioinformatics, which the students will learn through course work and extensive laboratory training. Students in this program will receive training in the application of biotechnology to basic and applied cancer research, and to the dissemination of information to the next generation of scientists and the lay public. Training will include exercises designed to develop independent thinking, oral and written presentation skills, data and information analysis, and dissemination of information through teaching. Students in this program will enter their graduate careers at OHSU through the  Program in Molecular and Cellular Biology .

PMCB is an interdisciplinary program that brings together over 150 faculty from seven basic science departments and research institutes to provide graduate students with rigorous training in chemical, molecular, cellular, and systems biology during their first year at OHSU. The first-year curriculum consists of courses that all students will take, and emphasizes all aspects of cancer biology (cellular, molecular, systems, and disease). The curriculum is flexible and courses are largely completed in the first term, permitting students to focus on the essence of graduate training, independent research in a mentor's laboratory, as soon as possible.

First year students will be advised by faculty members, who will guide them through courses including advanced electives and rotations. Students also participate in laboratory rotations in the first year, using these rotations to help choose a dissertation lab. At the end of the first year, students will take a comprehensive written exam, which tests students on their grasp of the core curriculum and on their skills in understanding the primary literature. Also at the end of the first year, the students choose a mentor and officially enter the Program in Cancer Biology. At the end of their second year, students take the oral qualifying exam, which allows them to become a Ph.D. candidate. The qualifying exam consists of a written component, which is a thesis proposal in the format of an NRSA grant, and an oral defense. Subsequently, the student chooses a dissertation advisory committee, who guides their dissertation research. Students are evaluated at several points during their participation in the program, and are subjected to several yearly requirements, including a dissertation committee meeting and a talk on their research. Finally, the culmination of a student's graduate career is the assembly of a written Ph.D. dissertation and its oral defense. Thus, the proposed program combines rigorous course work with laboratory training and exercises in writing, speaking, and teaching, designed to provide students with the necessary theoretical and practical skills to launch productive careers.

Graduating students will be in a position to competitively pursue a wide range of potential careers including: basic and applied research in the academic, biotechnology and pharmaceutical industries, as well as in undergraduate and graduate level teaching and science writing. 

Mailing Address Cancer Biology Graduate Program, L357 3181 S.W. Sam Jackson Park Road Portland, OR 97239

Graduate Program Coordinator Lola Bichler 503-494-5824 Email  

Admissions information Program in Molecular and Cellular Biology 503-494-3467 Email

Graduate Studies 503-494-6222 Email

Initiatives

Our community.

• Education & Admissions

Cancer Biology

The cancer biology area of research emphasis is oriented towards modern molecular and cellular biology, molecular genetics, cellular biochemistry, and immunology especially in those areas dealing with mechanisms controlling neoplastic transformation, cellular division, differentiation, apoptosis, invasion, and metastasis. Current research of more than fifty participating faculty members in cancer biology is very diverse and includes investigations in the fields of cancer immunology, DNA replication, transcription, chromatin remodeling, molecular genetics, signal transduction, chemical carcinogenesis and the regulation of oncogenes and tumor suppressor genes.

The abilities of cancer biologists to elucidate basic mechanisms of cellular transformation and molecular events in tumor progression are being applied toward improving diagnosis and treatment of cancer. In addition, cancer biologists in our program are contributing toward the understanding of basic mechanisms of growth control and cellular differentiation that can be universally applied to other disciplines, such as developmental biology, virology, immunology, and genetics. Our graduate faculty members come from diverse disciplines and conduct basic, translational and clinical research.

Anne Strohecker, PhD and Deepa Sampath , PhD Faculty Liaisons

Program Curriculum

Requirements

Due to its interdisciplinary nature, the course requirement of the cancer biology area of research emphasis is diverse and flexible. Students select from the following list of recommended courses related to cancer biology. Students also attend appropriate seminars to meet the seminar requirement.  In addition to the core curriculum, to receive the transcript designation of cancer biology, a student must complete six credit hours from the following courses:

• CBG 7010 - 100 Cellular and Molecular Immunology (3 units): Cellular and molecular mechanisms of immune response, cell recognition and communication, molecular biology of cell recognition structures, cytokines and effector mechanisms.
• CBG 8270 - 10 Biochemical Mechanisms of Carcinogenesis (2 units): Provide students with an overview of fundamental mechanisms leading to cancer.  This will be done through review of current and classic literature.
• MOLBIOC 5733 (2 units): The principles of human genetics covering mapping of disease genes, defects causing human disease, the cloning of disease genes, gene therapy, transgenes, and specific pathological disorders.
• MOLBIOC 7823 - 10 Control of Cell Growth and Proliferation (2 units): Role of cell stress response, cytoplasmic signaling molecules, transcription factors and chromatin remodeling complexes in the regulation of cell growth, cell death, and in mechanisms causing cancer.
• MOLBIOC 7807 - 10 Gene Expression: Post-Transcriptional Control (3 units): Intensive study of problems in the general area of post-transcriptional control of gene expression. The course consists of student presentations and class evaluations of recently published results in these fields.
• MOLGEN 5300 Cancer Genetics: Students will learn about the genetic evolution of human cancer. Specifically, the hallmarks of cellular transformation and tumor progression will be discussed. Students will be introduced to modern approaches aimed at targeting genetic aberrations in cancer cells. Includes hands-on training in the use of online databases of cancer genetics.
• MOLGEN 7741 - 0010   Molecular Biology and Pathogenesis of Viruses (5 units): An integrated study of the molecular mechanisms of virus replication and host-virus relationships that control virus pathogenesis or use as a therapeutic agent.
• NGSY 8250 Biology of the tumor microenvironment (2 units): Cellular and molecular biology of the microenvironment in solid cancers. Signals and mechanisms that promote tumor initiation and progression.
• PATHOL 6640 - 1100   Fundamentals of Oncology (4 units): Oriented towards graduate students in cancer-related programs and consists of a series of lectures covering a variety of aspects of experimental oncology.
• PATHOL 6670 - 0010   Medical Cytogenetics (3 units): Overview of cytogenetics in medical diagnosis and evaluation, including laboratory techniques, nomenclature, structural and numerical chromosome abnormalities; prenatal, constitutional, molecular, and cancer cytogenetics. Recommended coursework in genetics and molecular cell biology.

Due to the interdisciplinary nature of cancer biology, students can meet their seminar requirement by taking the following courses. To receive this special graduate designation, students will be required to register for a total of four credit hours of seminars in molecular biology, genetics, immunology, or cancer related topics.

Helpful Links

• See Something, Say Something
• BSGP Student Handbook PDF
• Contact Biomedical Sciences Graduate Program 1022 Graves Hall , 333 W. 10th Ave Columbus, OH 43210  614-685-9140 [email protected]  

Best Global Universities for Oncology in the United States

These are the top universities in the United States for oncology, based on their reputation and research in the field. Read the methodology »

To unlock more data and access tools to help you get into your dream school, sign up for the  U.S. News College Compass !

Here are the best global universities for oncology in the United States

Harvard university, johns hopkins university, cornell university, university of california san francisco, yale university, university of california los angeles, vanderbilt university, university of pennsylvania, university of washington seattle, university of michigan.

See the full rankings

• Clear Filters

• # 1 in Best Universities for Oncology
• # 1 in Best Global Universities

Founded in 1636, Harvard University is the oldest higher education institution in the U.S. The bulk of Harvard's... Read More

• # 2 in Best Universities for Oncology
• # 10 in Best Global Universities

Johns Hopkins University is a private institution that was founded in 1876. The school has campuses located in and... Read More

• # 3 in Best Universities for Oncology
• # 21 in Best Global Universities

Cornell University is a private institution that was founded in 1865. The Ivy League school is located in Ithaca, New... Read More

• # 4 in Best Universities for Oncology
• # 16 in Best Global Universities  (tie)

The University of California—San Francisco is a public institution that was founded in 1864. The health sciences-focused... Read More

• # 6 in Best Universities for Oncology
• # 11 in Best Global Universities

Yale University was founded in 1701, making it one of the oldest institutions of higher education in the U.S. The... Read More

• # 7 in Best Universities for Oncology
• # 14 in Best Global Universities

The University of California—Los Angeles, commonly referred to as UCLA, is a public institution that was founded in... Read More

• # 9 in Best Universities for Oncology
• # 78 in Best Global Universities

• # 10 in Best Universities for Oncology
• # 15 in Best Global Universities

The University of Pennsylvania, also known as Penn, was founded in 1740. The private, Ivy League institution is located... Read More

• # 11 in Best Universities for Oncology
• # 6 in Best Global Universities

The University of Washington is a public institution that was founded in 1861. The school's oldest and largest campus in... Read More

• # 12 in Best Universities for Oncology
• # 19 in Best Global Universities

The University of Michigan—Ann Arbor is a public institution that was founded in 1817 and made the city of Ann Arbor its... Read More

Program in Cancer Biology

Mission of the Program in Cancer Biology

To train new leaders in the field of Cancer Biology that will develop new knowledge that will translate into improved detection, diagnosis, prognosis, prevention, or treatment of cancer.

Research Areas of Emphasis

• Cancer Immunity, host tumor interactions, and angiogenesis
• Cancer Precision Medicine—targeted therapies and drug resistance using mouse modeling, human tumor tissues, and systems approaches
• Bioinformatic analyses of tumor heterogeneity including genome, proteome, metabolome, and immunome components during tumor progression
• Basic Cancer Biology—tumor progression, invasion and metastasis

Steering Committee

Ann Richmond, Program Director Rachelle Johnson, Director of Graduate Studies Jin Chen Barbara Fingleton Vito Quaranta Jeffrey Rathmell W. Kimryn Rathmell Julie Rhoades Alissa Weaver Chris Williams

News & Events

Jared Rhodes (Mentor James Goldenring, MD, PhD)

Jared won the best student graduate poster at the 23rd Annual Retreat for Cancer Biology! His research in Goldenring Lab examines fibroblasts and how they have recently been shown to promote the dysplastic transition of metaplastic lineages in the stomach. Specifically, conditioned media (CM) from gastric metaplasia and cancer-derived fibroblasts accelerated dysplastic progression in metaplastic gastroids. It remains unclear which factors secreted from fibroblasts cause this progression. Therefore, he performed scRNA-sequencing on normal, metaplasia, and cancer-derived fibroblasts. This revealed expression differences of many secreted factor encoding genes. Metaplastic gastroids were cultured in 30 and 50 kDa filtered CM from cancer-derived fibroblasts to narrow down candidate factors. 30 kDa filtrate CM enhanced dysplastic progression of metaplastic gastroids compared to 50 kDa filtrate. Therefore, they looked specifically for genes encoding 30 kDa or fewer proteins and found high SPON2 expression only in metaplasia and cancer-derived fibroblasts. SPON2 is a 30 kDa secreted protein shown to promote the proliferation and migration of gastric cancer cells. Therefore, they hypothesize that fibroblasts secrete SPON2 to induce dysplasia. The presence of SPON2 in CM was confirmed with mass spectrometry, detecting SPON2 only in metaplasia and cancer-derived fibroblast CM. Furthermore, STAT3 inhibition was evaluated because SPON2 has been shown to promote downstream signaling through STAT3. A STAT3 inhibitor suppressed the effect of cancer-derived fibroblast CM in the dysplastic progression of metaplastic gastroids. These are the first studies investigating fibroblast-derived SPON2 in the induction of precancerous gastric dysplasia. Understanding factors that contribute to gastric dysplasia represents an important area of research, as gastric cancer remains one of the leading causes of cancer-related deaths worldwide.

Yunli (Emily) Chu (Mentor Brent Ferrell, PhD)

Emily won the Best Talk award at the 23rd Annual Retreat in Cancer Biology! Emily’s research discusses Cytotoxic chemotherapy, which has been the mainstay of acute myeloid leukemia (AML) treatment. There are no approved immunotherapies for AML due to our limited understanding of how CD8+ T cells respond to AML progression. To investigate CD8+ T cell dynamics in AML, we transplanted leukemic cells bearing the MLL-AF9 translocation into immunocompetent mice. Leukemic mice exhibited a shift in CD8+ T cell phenotype toward activation, characterized by reduced naive cells, increased effector cells, and elevated CD69 expression. Surprisingly, high-dimensional phenotyping using mass cytometry identified an enrichment of PD-1 and LAG-3 expressing T cells. Ex vivo stimulation demonstrated heightened TNF-α and IFN-γ production by leukemia-associated T cells. To test if the cytokine milieu is sufficient to induce the phenotypic changes, we stimulated isolated, naive CD8+ T cells in conditioned media containing serum from healthy or leukemic mice. Interestingly, exposure to the AML cytokine milieu alone failed to induce the phenotypic changes observed in vivo. These findings suggest that other factors, such as receptor-ligand interactions and nutrient competition, may play more prominent roles in shaping T-cell responses in AML. In summary, these studies highlight that AML can profoundly influence the phenotype and function of CD8+ T cells. AML induces a dysfunctional phenotype in CD8+ T cells, though functionally, these cells produced more cytokines. It is possible that the secretion of inflammatory cytokines by CD8+ T cells contributes to AML cell proliferation. Future studies will focus on the mechanisms underlying phenotypic changes and immune escape in AML, seeking ways to disrupt these interactions.

• About the School
• Quick Facts
• Administration
• Basic Sciences
• A-Z Directory
• Contact Information
• Campus Maps & Parking

• Current Students
• Basic Sciences Faculty Affairs
• Clinical Faculty Affairs
• Eskind Biomedical Library
• People Finder

Cancer Institute MPhil/PhD

London, Bloomsbury

A full or part-time research degree at the UCL Cancer Institute offers an unrivalled foundation for building a career in cancer. World-class facilities, expert supervision and wide-ranging training opportunities will give you the skills and network to help shape cancer research and practice in academia, biomedicine, or healthcare.

UK tuition fees (2024/25)

Overseas tuition fees (2024/25), programme starts, applications accepted.

• Entry requirements

A minimum of an upper second-class UK Bachelor’s degree in a relevant discipline or an overseas qualification of an equivalent standard.

The English language level for this programme is: Level 3

UCL Pre-Master's and Pre-sessional English courses are for international students who are aiming to study for a postgraduate degree at UCL. The courses will develop your academic English and academic skills required to succeed at postgraduate level.

Further information can be found on our English language requirements page.

Equivalent qualifications

Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website .

International applicants can find out the equivalent qualification for their country by selecting from the list below. Please note that the equivalency will correspond to the broad UK degree classification stated on this page (e.g. upper second-class). Where a specific overall percentage is required in the UK qualification, the international equivalency will be higher than that stated below. Please contact Graduate Admissions should you require further advice.

About this degree

Research within the UCL Cancer Institute is diverse and spans various disciplines including molecular and cellular biology, cancer genetics, immunology, genetic engineering, cancer therapeutics and bioinformatics.

Research students on this programme join one of five research departments within UCL ' s Cancer Institute:

• Cancer Biology
• Haematology
• Clinical Trials.

You will develop your research hypothesis with your supervisors and undertake novel laboratory, bioinformatic or clinical research as part of their research team. You will regularly discuss your data and analyses with your supervisors and share your findings in a variety of forums, ideally leading to presentations at conferences and publication of your work.

Knowledge and skills development is a core priority of the programme, and you will be supported in this area by a supervisory team. In addition to your principal supervisor, you will have a thesis committee which comprises a secondary (subsidiary) supervisor and between one and three thesis committee members.

In your first year, you will have a compulsory training programme run by the Cancer Institute that will improve your research skills and provide networking opportunities. This is in addition to the optional research methods modules offered on the UCL Doctoral Skills Training Programme.

Who this course is for

This course will appeal to high achieving students who want to join a world-class centre in cancer research. It is suitable if you have a strong academic background as a clinician, scientist, or other profession focused on cancer. We welcome students come from around the world and your study will be based in London.

What this course will give you

This programme offers you the following benefits and opportunities.

• A collaborative research environment that spans basic research, translational medicine, and clinical applications.
• Close links with associated clinical trials facilities, experimental cancer medicine centres, biobanking facilities and associated partners and hospitals in London such as the Royal Free Hospital, UCL Hospitals (UCLH), Cancer Research UK and the Crick Institute.
• Developing skills including bench and technical skills, critical evaluation of scientific literature, experimental planning and design, interpretation of data results, presentation/public speaking skills, time and project management, working within a team, working independently, and writing for various audiences.

Making an impact

Case study: Catching and treating more prostate cancers worldwide

Thanks to UCL research, millions of men each year benefit from more accurate diagnosis and treatment of prostate cancer with significantly fewer side effects.

The foundation of your career

Our excellent facilities, supervision and training opportunities prepare you for future careers in academic posts, industry, business, biomedicine, and healthcare.

The lecture on CAR-T for the Cancer MSc programme was the first time I can remember thinking 'Wow! I am interested in this.' Now, my PhD involves the targeting of a glioblastoma-specific antigen and exploring different constructs. Morgan Palton Cancer Institute, PhD Learn more about Morgan

Employability

Graduates go on to academic posts at universities around the world. Other career pathways include laboratory management, research, industry, clinical trials co-ordination, scientific writing and editing, and sales and consulting.

You will also be well placed to go onto further medical training or to take up a clinical post.

The programme is designed to give you networking opportunities throughout your period of study.

These include weekly internal divisional seminars, a fortnightly external speaker seminars and reception, and student poster sessions. You will also attend the annual Cancer Institute Conference, as well as national and international research conferences, and academic careers days.

After graduating, you will be able to join the Institute's alumni network on LinkedIn.

Teaching and learning

Most of your research will be carried out independently. There will also be a series of training requirements that you will need to complete in the early stages of the programme.

All research students attend a training programme on lab skills from January to July in the first year, which covers:

• Human Tissue Act and the Biobank
• Tissue Preparation and Staining
• Basics of Proteomics
• Principles of Good Clinical Lab Practice
• Clinical Trial Design and Regulation
• In vivo Study Design and Regulation
• Preclinical Radiotherapy
• Single Cell Analysis.

Your first milestone will be to upgrade from MPhil to the PhD degree. For this, you will submit and present a report. In your final year, you submit a thesis covering your research and discuss this at a formal interview known as a viva examination.

Most of your time will be spent conducting independent research, alongside regular meetings with your supervisory team and completing your training requirements. We also encourage you to attend relevant research events at UCL and elsewhere.

Research areas and structure

• Antibody-based therapeutics for imaging and treatment of cancer
• Brain cancer and stem cells
• Cellular and gene therapy for cancer and other blood-related disorders
• Chromosomal DNA replication and cancer
• Effects of tumour biology on therapeutic response, tumour immunology
• Epigenetic changes and cancer
• Genetics of sarcoma, acute leukaemia, chronic leukaemia and myoproliferative diseases
• Medical genomics, cancer systems, science and biomedical informatics
• Signalling networks
• Stratified/personalised cancer medicine
• Therapeutic drug-DNA interactions
• Translational projects, clinical trials and epidemiology
• Viral oncology.

Research environment

UCL is a top-rated university in the UK for research strength in the Research Excellence Framework (REF 2021). Our scientists have an international reputation for leading basic, translational, and clinical cancer research and the Cancer Institute is uniquely positioned to leverage the multidisciplinary nature of UCL by engaging a range of disciplines to transform cancer research.

You will join a community of over 300 research scientists and 120 research students within the Cancer Institute. Our combination of fundamental cancer research, clinical links with UCLH and the Royal Free Hospitals, and collaborative links with the Crick Institute and Cancer Research UK, make the Cancer Institute an exciting environment for basic and translational research into cancer.

In addition to individual supervision from your thesis committee and the UCL Doctoral Skills Development Programme, the Cancer Institute runs a series of skills workshops between January and October of your first year. Some of these are project specific, such as knowledge and intellectual abilities, statistics analysis, and writing research papers or grants.

Other training focuses on transferable skills, including personal effectiveness, engagement influence and impact, research governance and organisation, and networking. You can also gain training credits by doing certain activities which are listed on the Cancer Institute Training page .

You will be invited to discuss your data and conclusions at research team meetings, Institute Research in Progress talks, the annual Cancer Institute conference and Research Student poster day. You will also be encouraged to present at relevant international conferences and, where appropriate, to contribute towards scientific publications in your field.

The length of registration for research degrees is usually three to four years for full-time study.

When you accept your place on the programme, you will initially register for an MPhil. You will be eligible to upgrade to PhD student status between 9-18 months.

Within three months of joining the programme, you will be expected to agree the basic structure of your research project with your supervisor, along with the appropriate research methods and a realistic plan of your work.

You will then need to produce and submit a detailed outline of your proposed research for comments and feedback. Following that, you will be ready to undertake the project as part of your supervisor’s research team, sharing your ideas and drawing on the knowledge, expertise, and support of the team.

In your second year, you will continue to explore your research hypothesis and collect and analyse novel data. You will also be expected to upgrade from an MPhil to a PhD.

To successfully upgrade to a PhD, you will need to submit a report summarising your research to date, and to present and answer questions about this work at a viva examination. You will also be expected to present your research to the department at a Research in Progress seminar.

In your third year, you will be expected to complete your data collection and analysis, and to prepare your thesis. You will also be encouraged to present your findings at an international conference or the annual Cancer Institute conference.

Following your third year, you may be eligible to transfer to what is termed 'completing research status' for one year to complete your thesis writing and final viva examination.

The length of registration for the research degrees is usually five years for part-time study.

When you accept your place on the programme, you will initially register for an MPhil. You will be eligible to upgrade to PhD student status between 15-30 months.

Within five months of joining the programme, you will be expected to agree the basic structure of your research project with your supervisor, along with the appropriate research methods and a realistic plan of your work.

In your second and third years (18-36 months), you will continue to explore your research hypothesis and collect and analyse novel data. You will also be expected to upgrade from an MPhil to a PhD.

In your fourth and fifth years, you will be expected to complete your data collection and analysis, and to prepare your thesis. You will also be encouraged to present your findings at an international conference or the annual Cancer Institute conference.

Following the fifth year, you may be eligible to transfer to what is termed 'completing research status' for two years to complete your thesis writing and final viva examination.

Accessibility

Details of the accessibility of UCL buildings can be obtained from AccessAble accessable.co.uk . Further information can also be obtained from the UCL Student Support and Wellbeing team .

Where you'll study

At the UCL Cancer Institute, you will join a scientific community of over 400 talented scientists. We are dedicated to discovering new techniques in cancer detection and treatment that can make a different to the lives of cancer patients. Our undergraduate, taught masters and PhD programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Teaching is predominantly based at the Hampstead and Bloomsbury campuses.

Fees and funding

Fees for this course.

The tuition fees shown are for the year indicated above. Fees for subsequent years may increase or otherwise vary. Where the programme is offered on a flexible/modular basis, fees are charged pro-rata to the appropriate full-time Master's fee taken in an academic session. Further information on fee status, fee increases and the fee schedule can be viewed on the UCL Students website: ucl.ac.uk/students/fees .

Additional costs

Students receive a free printing allowance each year and pay for any additional printing ( see details ). You may also face additional expenses if you attend conferences. The cost depends on the location, exchange rates, and the price of travel and accommodation, but this may be between £200 and £500 per event, based on typical events / destinations attended by recent students. The Cancer Institute provides two competitive travel scholarships each year to support research students attending training workshops or international conferences.

If you are doing a wet lab project, there may be an Additional Fee Element (AFE, also known as bench fees). This is an additional annual cost related to consumables, equipment or materials based on your individual project. This is payable by your sponsor, or yourself, if self-funding. These additional costs depend on the project and will be the same for home and overseas students.

For more information on additional costs for prospective students please go to our estimated cost of essential expenditure at Accommodation and living costs .

Funding your studies

Annual CR-UK funded clinical fellowships and non-clinical PhD studentships are available. Please check the Cancer Institute website for details. Other funded studentships will also be advertised on the Institute's website as they become available. Some of our students seek funding from their home country or cancer charities.

For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website .

Your first steps are to find a supervisor and funding before applying. You should check both the UCL and the Cancer Institute's studentships to apply for specific projects with grants. You can also reach out directly to any potential supervisor, particularly if you have funding in place from another source. You can identify Principal Investigators via the Cancer Institute website and research them individually. If you need help, please see applying for graduate research study or contact the Admissions Tutor on [email protected].

You can apply at any time. However, there are three entry points over the year. Deadlines and start dates are usually dictated by funding arrangements and supervisor availability, so discuss this with your supervisors.

Please note that you may submit applications for a maximum of two graduate programmes (or one application for the Law LLM) in any application cycle.

Choose your programme

Please read the Application Guidance before proceeding with your application.

Year of entry: 2024-2025

Got questions get in touch.

Cancer Institute

[email protected]

UCL is regulated by the Office for Students .

Prospective Students Graduate

• Graduate degrees
• Taught degrees
• Taught Degrees
• Applying for Graduate Taught Study at UCL
• Research degrees
• Research Degrees
• Funded Research Opportunities
• Doctoral School
• Funded Doctoral Training Programmes
• Applying for Graduate Research Study at UCL
• Teacher training
• Teacher Training
• Early Years PGCE programmes
• Primary PGCE programmes
• Secondary PGCE programmes
• Further Education PGCE programme
• How to apply
• The IOE approach
• Teacher training in the heart of London
• Why choose UCL?
• Entrepreneurship
• Inspiring facilities and resources
• Careers and employability
• Your global alumni community
• Your wellbeing
• Postgraduate Students' Association
• Your life in London
• Accommodation
• Funding your Master's